• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素耐药性的预防与潜在补救措施:当前研究与未来展望

Prevention and potential remedies for antibiotic resistance: current research and future prospects.

作者信息

Khan Rabiya Tabbassum, Sharma Vanshika, Khan Sofia Sharief, Rasool Shafaq

机构信息

Molecular Biology Lab, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India.

出版信息

Front Microbiol. 2024 Oct 3;15:1455759. doi: 10.3389/fmicb.2024.1455759. eCollection 2024.

DOI:10.3389/fmicb.2024.1455759
PMID:39421555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11484029/
Abstract

The increasing threat of antibiotic resistance and shrinking treatment options for infections have pushed mankind into a difficult position. The looming threat of the return of the pre-antibiotic era has caused a sense of urgency to protect and conserve the potency of antibiotic therapy. One of the perverse effects of antibiotic resistance is the dissemination of its causative agents from non-clinically important strains to clinically important strains and vice versa. The popular saying "Prevention is better than cure" is appropriate for tackling antibiotic resistance. On the one hand, new and effective antibiotics are required; on the other hand, better measures for the use of antibiotics, along with increased awareness in the general public related to antibiotic use, are essential. Awareness, especially of appropriate antibiotic use, antibiotic resistance, its dissemination, and potential threats, can help greatly in controlling the use and abuse of antibiotics, and the containment of antibiotic resistance. Antibiotic drugs' effectiveness can be enhanced by producing novel antibiotic analogs or adding adjuvants to current antibiotics. Combinatorial therapy of antibiotics has proven successful in treating multidrug-resistant (MDR) bacterial infections. This review aims to highlight the current global situation of antibiotic resistance and discuss the methods used to monitor, prevent, inhibit, or reverse bacterial resistance mechanisms in the fight against antibiotic resistance.

摘要

抗生素耐药性威胁的不断增加以及感染治疗选择的日益减少,使人类陷入了困境。抗生素前时代回归的潜在威胁引发了保护和保存抗生素治疗效力的紧迫感。抗生素耐药性的一个不良影响是其病原体从非临床重要菌株传播到临床重要菌株,反之亦然。“预防胜于治疗”这句俗语适用于应对抗生素耐药性问题。一方面,需要新型有效的抗生素;另一方面,更好的抗生素使用措施以及提高公众对抗生素使用的认识至关重要。提高认识,特别是对抗生素的合理使用、抗生素耐药性、其传播以及潜在威胁的认识,有助于极大地控制抗生素的使用和滥用,并遏制抗生素耐药性。通过生产新型抗生素类似物或在现有抗生素中添加佐剂,可以提高抗生素药物的有效性。抗生素联合疗法已被证明在治疗多重耐药(MDR)细菌感染方面是成功的。本综述旨在突出当前抗生素耐药性的全球形势,并讨论在抗击抗生素耐药性过程中用于监测、预防、抑制或逆转细菌耐药机制的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/618d83f77d06/fmicb-15-1455759-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/077154784215/fmicb-15-1455759-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/d47014c2b501/fmicb-15-1455759-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/618d83f77d06/fmicb-15-1455759-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/077154784215/fmicb-15-1455759-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/d47014c2b501/fmicb-15-1455759-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f4/11484029/618d83f77d06/fmicb-15-1455759-g003.jpg

相似文献

1
Prevention and potential remedies for antibiotic resistance: current research and future prospects.抗生素耐药性的预防与潜在补救措施:当前研究与未来展望
Front Microbiol. 2024 Oct 3;15:1455759. doi: 10.3389/fmicb.2024.1455759. eCollection 2024.
2
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.抗生素耐药菌:现状与治疗选择,以加速新抗菌药物的研发。
Expert Rev Anti Infect Ther. 2022 Aug;20(8):1095-1108. doi: 10.1080/14787210.2022.2078308. Epub 2022 May 31.
3
Vesicoureteral Reflux膀胱输尿管反流
4
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.微生物的抗生素耐药性:历史、机制、治疗策略和未来前景。
J Infect Public Health. 2021 Dec;14(12):1750-1766. doi: 10.1016/j.jiph.2021.10.020. Epub 2021 Oct 23.
5
Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens.抗生素佐剂:应对多重耐药病原体的协同工具。
Front Cell Infect Microbiol. 2023 Dec 20;13:1293633. doi: 10.3389/fcimb.2023.1293633. eCollection 2023.
6
Assessment of Antimicrobial Resistance Dissemination Dynamics during Multidrug-Resistant-Bacterium Invasion Events by Using a Continuous-Culture Device.利用连续培养装置评估多重耐药菌入侵事件中抗菌药物耐药性传播动力学。
Appl Environ Microbiol. 2021 Feb 26;87(6). doi: 10.1128/AEM.02659-20.
7
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.头孢他啶-阿维巴坦、头孢洛扎-他唑巴坦、头孢地尔、新型达罗巴坦类似物对儿科和青少年囊性纤维化患者多药耐药铜绿假单胞菌分离株的抗菌活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0443722. doi: 10.1128/spectrum.04437-22. Epub 2023 Jan 24.
8
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.应对多重耐药菌的威胁及未来问题
Curr Top Microbiol Immunol. 2016;398:3-33. doi: 10.1007/82_2016_492.
9
Genomic Comparison Reveals Natural Occurrence of Clinically Relevant Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strains.基因组比较揭示了临床相关多药耐药型产extended-spectrum-β-lactamase 的大肠杆菌菌株的自然发生。
Appl Environ Microbiol. 2019 Jun 17;85(13). doi: 10.1128/AEM.03030-18. Print 2019 Jul 1.
10
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.三聚氰胺乌洛托品与抗生素预防用药预防女性复发性尿路感染的比较:ALTAR 非劣效 RCT。
Health Technol Assess. 2022 May;26(23):1-172. doi: 10.3310/QOIZ6538.

引用本文的文献

1
Next generation antimicrobial peptide disinfectant targeting biocide and vancomycin resistant staphylococcus aureus through integrated in Silico and in vitro validation.通过整合计算机模拟和体外验证,针对具有生物杀灭剂和万古霉素抗性的金黄色葡萄球菌的下一代抗菌肽消毒剂。
Sci Rep. 2025 Aug 1;15(1):28108. doi: 10.1038/s41598-025-12736-7.
2
Advancements in Antibacterial Therapy: Feature Papers.抗菌治疗的进展:专题论文
Microorganisms. 2025 Mar 1;13(3):557. doi: 10.3390/microorganisms13030557.
3
Discovery and Characterization of an Atypical Crustin Antimicrobial Peptide from .

本文引用的文献

1
Targeting bacterial biofilm-related genes with nanoparticle-based strategies.利用基于纳米颗粒的策略靶向细菌生物膜相关基因。
Front Microbiol. 2024 May 22;15:1387114. doi: 10.3389/fmicb.2024.1387114. eCollection 2024.
2
Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant .鉴定激酶调节剂作为针对细胞内耐甲氧西林金黄色葡萄球菌的宿主定向治疗药物。
Front Cell Infect Microbiol. 2024 Mar 25;14:1367938. doi: 10.3389/fcimb.2024.1367938. eCollection 2024.
3
Unraveling resistance mechanisms in combination therapy: A comprehensive review of recent advances and future directions.
来自……的一种非典型甲壳素抗菌肽的发现与表征
Mar Drugs. 2024 Nov 22;22(12):526. doi: 10.3390/md22120526.
4
Patterns of antibiotic resistance genes and virulence factor genes in the gut microbiome of patients with osteoarthritis and rheumatoid arthritis.骨关节炎和类风湿关节炎患者肠道微生物群中抗生素耐药基因和毒力因子基因的模式
Front Microbiol. 2024 Nov 20;15:1427313. doi: 10.3389/fmicb.2024.1427313. eCollection 2024.
5
Affinity of cefditoren for penicillin-binding proteins in bacteria and its relationship with antibiotic sensitivity.头孢地尼与细菌青霉素结合蛋白的亲和力及其与抗生素敏感性的关系。
Arch Microbiol. 2024 Nov 18;206(12):469. doi: 10.1007/s00203-024-04194-y.
解析联合治疗中的耐药机制:近期进展与未来方向的全面综述
Heliyon. 2024 Mar 11;10(6):e27984. doi: 10.1016/j.heliyon.2024.e27984. eCollection 2024 Mar 30.
4
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.纳米技术在防治感染性和炎症性疾病方面的前沿应用:预防与治疗。
Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z.
5
Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward.通过尽量减少抗生素使用增强低收入和中等收入国家抗击抗菌药物耐药性的能力:前进之路
Antibiotics (Basel). 2023 Oct 2;12(10):1504. doi: 10.3390/antibiotics12101504.
6
Awareness Regarding Antimicrobial Resistance and Antibiotic Prescribing Behavior among Physicians: Results from a Nationwide Cross-Sectional Survey in India.医生对抗菌素耐药性的认识及抗生素处方行为:印度全国横断面调查结果
Antibiotics (Basel). 2023 Sep 29;12(10):1496. doi: 10.3390/antibiotics12101496.
7
Restoring susceptibility to aminoglycosides: identifying small molecule inhibitors of enzymatic inactivation.恢复对氨基糖苷类药物的敏感性:鉴定酶促失活的小分子抑制剂。
RSC Med Chem. 2023 Jul 21;14(9):1591-1602. doi: 10.1039/d3md00226h. eCollection 2023 Sep 19.
8
Gold-Based Nanostructures for Antibacterial Application.基于金的纳米结构在抗菌应用中的研究
Int J Mol Sci. 2023 Jun 11;24(12):10006. doi: 10.3390/ijms241210006.
9
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits -Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum.新型硼酸过渡态抑制剂 MB076 的合成:杂环三唑有效抑制具有扩展底物谱的 - 衍生头孢菌素酶变体。
J Med Chem. 2023 Jul 13;66(13):8510-8525. doi: 10.1021/acs.jmedchem.3c00144. Epub 2023 Jun 26.
10
Quorum sensing architecture network in Escherichia coli virulence and pathogenesis.大肠杆菌毒力与发病机制中的群体感应结构网络。
FEMS Microbiol Rev. 2023 Jul 5;47(4). doi: 10.1093/femsre/fuad031.